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Abstract
One major difficulty in interpreting the changes occurring during liver regeneration is the co-existence of non-activated
 .cells and proliferating hepatocytes at all stages of differentiation. The aim of this study was to investigate bile acid BA
 .  .secretion into bile during normal NLR and synchronized SLR liver regeneration in rats. Regeneration was synchronized
 .by reversible inhibition of ribonucleotide reductase by 10 h treatment with hydroxyurea HU shortly after two-third partial
hepatectomy. Total BA output as measured by GC–MS increased immediately after partial hepatectomy. This was followed
by a further transient enhancement during the next day in the NLR. HU treatment did not significantly modify total BA
output, but after releasing synchronized regeneration a marked reduction was observed. This was followed by a recovery to
reach values close to those of NLR on day 7 of the regenerative process in SLR. Amidated BA output as measured by
HPLC analysis revealed an early enhancement in the proportion of non-conjugated BAs in bile in NLR. However, the
profile of conjugated BAs, which was not affected by HU treatment, matched that of total BAs during the first stage of
SLR. By contrast, the increase in BA output observed on day 3 of the regenerative process in this group was accounted for
by an enhancement in non-conjugated BA secretion. On day 7 of the regenerative process, the proportion of conjugated BA
in bile was restored to approximately 100% in this group. Most BA molecules were conjugated with taurine rather than with
glycine in all experimental groups, during both NLR and SLR. GC–MS determinations indicated that the magnitude of the
cholic acid predominance in all bile samples was significantly modified during liver regeneration. This was increased early
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 .3a-HSD, 3a-hydroxysteroid dehydrogenase; TIC, total ion chromatogram; CA, cholic acid 3a , 7a , 12a-trihydroxy-5b-cholanoic acid ;
 .  .CDCA, chenodeoxycholic acid 3a , 7a-dihydroxy-5b-cholanoic acid ; DCA, deoxycholic acid 3a , 12a-dihydroxy-5b-cholanoic acid ;
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 .after partial hepatectomy and declined toward control values after few 2–3 days. Enhancement in the cholic acid
predominance was due to a reduction in the proportion of all other major BAs, above all ursocholic acid and v-muricholic
acid. By contrast, minor BAs in normal control rat bile such as allo-cholic acid were increased during both NLR and SLR,
and remained at detectable levels up to day 7. Changes in the proportion of secreted BA species were similar in SLR and
NLR except that the early reduction in the proportion of BAs other than cholic acid was more pronounced in SLR and the
quantitative importance of the diversity in BA species was recovered earlier in SLR than in NLR. In summary, these results
indicate that profound changes in BA secretion during rat liver regeneration do occur. Most of them are probably related to
the existence of retro-differentiationrre-differentiation processes which are speeded up by hydroxyurea-induced synchro-
nization of the wave of hepatocyte proliferation. q 1997 Elsevier Science B.V.
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1. Introduction
Clinical observations reveal that in most chronic
hepatic diseases compensatory liver growth does oc-
cur. This is due to the fascinating ability of this organ
to regenerate after partial damage. Both in healthy
and sick livers, the rate of hepatocyte proliferation is
similar to the rate of physiological and pathological
cell death, respectively. However, after partial hepa-
tectomy, virtually all remaining hepatocytes are acti-
vated to leave the quiescent G0 phase of the cell
cycle and to undergo at least one round of prolifera-
tion. Thus, after two-thirds hepatectomy in the rat,
the normal amount of parenchymal liver cells in the S
phase, i.e., approximately 0.1%, increases to values
w xclose to 15% in 24 h 1 .
Compensatory liver growth is the result of com-
plex processes, involving both hyperplasia and hyper-
trophy under the control of many different factors
w x2–4 , which leads to restoration of the liver mass
w xwithin two weeks in small laboratory rodents 5,6 or
w xseveral months in humans 7 . The existence of an
inverse correlation between cell proliferation and dif-
w xferentiation has been widely documented 8 . It con-
cerns normal development, tumor formation and in
vitro cell systems. As to how this affects the hepato-
cytes is not yet well understood. Several reports
indicate the existence of enzymatic retro-differentia-
tion during hepatocarcinogenesis and liver regenera-
w xtion 9 . This can profoundly affect the contribution
of proliferating hepatocytes to overall liver function
w xafter partial hepatectomy 10 . In this sense, it is
worth noting that normal entrance of parenchymal
liver cells in the replicative process does not occur in
a synchronized way. A proliferation wave first affects
the periportal hepatocytes and then moves towards
the perivenous zone of the liver acini. This is proba-
bly of great physiological relevance, in that it retains,
or even enhances, the ability to perform certain spe-
cific liver functions needed to maintain animal home-
ostasis during regeneration. Thus, hepatocyte differ-
entiation is necessary, for example, in order to syn-
thesize albumin and coagulation factors; to maintain
steady state in plasma glucose concentrations, and to
secrete bile. Modifications occurring during normal
liver regeneration in the rat have been widely studied,
those concerning bile secretion having received par-
w xticular attention by others 11–14 and ourselves
w x15,16 . Beside important contributions to the knowl-
edge of the changes occurring in the regenerating
liver, one major difficulty in interpreting these results
is the existence of a very heterogeneous hepatocyte
population in the liver at that time, including non-
activated cells and proliferating hepatocytes at all
stages of differentiation. This is due to the fact that
both the entrance and the exit of the hepatocytes in
the cell cycle occur in an asynchronous way.
The aim of the present work was therefore to
investigate the effect of synchronization of hepato-
cyte proliferation on the time course of the ability of
the liver to quantitatively and qualitatively maintain
bile acid secretion. The synchronization method used
in this work was an adaptation of the well established
w xone reported by Rabes et al. 17 , which is based on
the stopping of hepatocyte proliferation at the G1rS
boundary of the cell cycle by hydroxyurea-induced
reversible inhibition of ribonucleotide reductase, the
key enzyme in the de novo pathway for deoxyribonu-
cleotide biosynthesis. In previous studies by our group
w x18 , we have confirmed that the release of the ri-
bonucleotide reductase activity 10 h later results in a
synchronized wave of proliferation by previously
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halted hepatocytes, which was characterized by a
peak of DNA synthesis at 4 h after resuming the
w xregenerative process 18 .
2. Materials and methods
2.1. Chemicals
 .  .Glycocholic acid GCA , taurocholic acid TCA ,
 .glycochenodeoxycholic acid GCDCA , taurochen-
 .odeoxycholic acid TCDCA , tauroursodeoxycholic
 .  .acid TUDCA , glycodeoxycholic acid GDCA , tau-
 .rodeoxycholic acid TDCA , taurolithocholic acid
 .  .TLCA and glycolithocholic acid GLCA were more
than 95% pure by thin-layer chromatography. These,
 .together with hydroxyurea HU , testosterone acetate,
5b-cholestane and 3a-hydroxysteroid dehydrogenase
 . 3a-HSD were purchased from Sigma St. Louis,
.  .MO . Glycoursodeoxycholic acid GUDCA was from
 .Calbiochem San Diego, CA . All other chemicals
 .were from Merck Darmstadt, Germany .
2.2. Animals
Non-fasting male Wistar CF rats approximately
. 250 g Animal House, University of Salamanca,
.Spain were used. They were fed on commercial-pel-
 .leted rat food Panlab, Madrid, Spain and water ad
libitum. Lighting was controlled by a timer that
permitted light between 8:00 a.m. and 8:00 p.m. All
animals received humane care as outlined in ‘Guide
for the Care and Use of Laboratory Animals’ NIH
.Publication no. 80–23, revised 1985 . Approximately
two-thirds hepatectomy was carried out under ether
anesthesia according to the classical method of Hig-
w xgins and Anderson 5 . Fourteen hours after surgery,
some rats received an i.v. bolus injection of HU
170 mmolr100 g body weight, dissolved in 150 mM
.NaCl followed by a continuous HU infusion
2.0 mmolrminr100 g body weight, at 10 mlrmin,
.for 10 h through a catheter inserted into the left
jugular vein and exteriorized at the back of the neck.
For the two previous weeks, on alternate days, the
rats were accustomed to spending the night in a
movement restriction device so they could be placed
in it for HU infusion with minimum stress.
2.3. Experimental protocol
Bile collection was performed in non-hepatecto-
 .mized animals Control group , in rats undergoing
partial hepatectomy followed by spontaneous regen-
 .eration NLR, normal liver regeneration , and in ani-
mals that after partial hepatectomy underwent syn-
chronization of liver regeneration by the HU infu-
sion-releasing procedure SLR, synchronized liver re-
.generation . Experiments started immediately after
 .partial hepatectomy day 0 , or 1, 3 or 7 days after
this surgical procedure in NLR groups, or 0 or 4 h, 1,
3 or 7 days after releasing the HU infusion in the
SLR groups. Surgery and bile collection were carried
out under sodium pentobarbital Nembutal N.R., Ab-
. bot, Madrid, Spain anesthesia 50 mgrkg body
.weight, i.p . A median laparotomy and cannulation of
the common bile duct were performed. A bile sample
was collected in preweighed vials for the first 60 min
after cannulation. At the end of the experimental
period the animals were killed by exsanguination.
Livers were removed and weighed.
2.4. Analytical methods
Bile flow was determined gravimetrically. The
concentrations of 3a-hydroxy-bile acids in bile were
w xmeasured enzymatically using 3a-HSD method 19 .
The accuracy of this method is compromised if the
amount of glucuronated plus sulfated bile acid species
at C3 position in the samples is not negligible. How-
ever, the absence of significant amount of these bile
acid derivatives was confirmed in rat bile samples by
carrying out 3a-hydroxy-bile acid measurement be-
fore and after enzymatic hydrolysis using sulfatase
 .  .EC 3.1.6.1 and b-glucuronidase EC 3.2.1.31 , both
 .from Sigma data not shown . Amidated species of
major bile acids were measured by reversed phase
HPLC analysis using a modification of the method of
w xLabbe et al. 20 . HPLC was performed using a
Spherisorb C8 column 5mm, 250=4.6 mm, Symta,
. Madrid, Spain with a gradient pump module Model
.126, Beckman, Madrid, Spain and a photo-diode-
 .array detector Model 168, Beckman set at 199 nm.
The system was controlled by an IBM computer
 .Model 30286, IBM, Portsmouth, UK using System
Gold software from Beckman. In brief, 50 ml of bile
were first diluted with 1 ml of a mixture of aceto-
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nitrile: 0.019 M ammonium carbamate pH 4.45
 .32 : 68, vrv , containing 200–300 nmol testosterone
acetate, which was used as internal standard. After
centrifugation at 13000 rpm, 20 ml of this mixture
was injected into the HPLC system. Chromatographic
separation was carried out at room temperature with a
flow and mobile phase gradient as described by
w xLabbe et al. 20 . Bile acid identification in this
HPLC system was established by comparison with
the elution times determined using commercial stan-
dards. In the case of conjugated a- and b-muricholic
acids, these were previously purified from rat bile by
HPLC and identified by GC–MS. Taurine- and
glycine-conjugation was identified by differences in
their polarity and hence retention times in HPLC. A
mixture of external standards was injected twice, both
prior to and after the series of experimental samples
to be chromatographed each day.
Amidated bile acids in bile samples were hydro-
lyzed enzymatically using cholylglycine hydrolase
w x21 . Unconjugated bile acids were then extracted
from the hydrolyzate by liquid–solid extraction in
C18 cartridges and, prior to bile acid derivatization,
 .5b-cholestane 45 pmol was added to the sample as
internal standard. Methyl ester derivatives were pre-
w xpared by reaction with ethereal diazomethane 22,23 .
Trimethylsilyl ether derivatives were prepared in
pyridine-hexamethyldisilazane-trimethylchlorosilane
 . w x3 : 2 : 1 by vol. overnight at room temperature 24 .
GC–MS analyses were carried out using a modifica-
w xtion of the method described by Malavolti et al. 21
on a gas chromatograph HP 5890 serie II, Hewlett-
.Packard, Madrid, Spain connected to a mass spec-
 .trometer HP 5972, Hewlett-Packard . To identify
individual bile acids and to measure their concentra-
tions, GC retention times and MS spectra were com-
pared with authentic standards. When these were not
available, identification was tentatively based on the
predicted fragmentation patterns for specific bile acid
w xstructures 25–27 .
Bile acids were quantified from their peak height
response absorbance at 199 nm wavelength in HPLC
.and total ion chromatogram – TIC – in GC–MS
calculated using standards. Since TIC did not differ
much between individual bile acids, when standards
of a particular bile acid were not available, the amount
of this bile acid was calculated as relative to the peak
height response obtained for cholic acid.
Bile acids as measured by GC–MS and HPLC
were compared with values obtained using the 3a-
HSD method in control animals. Values obtained by
GC–MS and HPLC techniques were very similar to
each other but approximately 70% of those found by
measuring 3a-hydroxysteroids in control bile. This
proportion was maintained for GC–MS and 3a-HSD
methods in all experimental groups. In this study,
values given for total bile acids are those obtained by
GC–MS analysis and for conjugated bile acids are
those obtained by HPLC analysis.
2.5. Statistical analysis
Results are expressed as means"S.E. For calcu-
lating the statistical significance of differences among
the groups the Student t-test and the Bonferroni
method of multiple-range testing were used, as appro-
priate. Statistical analysis was performed on a Macin-
tosh LC-III computer Apple Computer, Cupertino,
.CA with programs supplied by Apple Computer.
3. Results
Release of ribonucleotide reductase activity after
HU treatment, that is after ribonucleotide accumula-
tion within cells halted at the G1rS boundary, results
w xin synchronization of liver regeneration 17 . This is
characterized by a marked wave of increased DNA
synthesis for approximately 8 h with a peak at 4 h
w x18 . Nevertheless, HU treatment does not eject cells
from the G0 phase, but merely, by holding them at
the G1rS boundary for a while, renders the process
w xmore synchronous when it is allowed to proceed 17 .
This is why HU treatment does not speed up liver
 .regeneration as a whole Table 1 . However, it in-
duces differences in the time course of certain spe-
cific liver functions, such as bile formation, during
liver regeneration. As has been previously reported
w x28 , bile flow was increased immediately after two-
 .thirds partial hepatectomy Table 1 , in part due to
 .the enhanced total bile acid output Fig. 1 . By
contrast, it was reduced to control level at day 1 of
regenerative period in SLR and subsequently in-
 . creased at day 3 Table 1 . In the NLR group Fig.
 ..1 A , this situation was followed by a further tran-
sient enhancement over the next day. These values
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Table 1
Body weight, liver weight and bile flow in rats during normal or synchronized liver regeneration
  . .  .  .  .  .Group Time days d , h Body weight g Resected liver mass g Final liver weight g Bile flow mlrminrg liver
Control y 260"11 None 8.7"0.6 1.65"0.10
b aAfter partial hepatectomy 0 d 0 h 256"10 6.3"0.3 3.1"0.2 2.26"0.30
 .Normal liver regeneration NLR
b aRegenerative period 1 d 278"15 6.7"0.4 4.2"0.2 2.21"0.21
a c3 d 277"12 6.9"0.4 6.3"0.3 2.48"0.17
7 d 267"10 6.1"0.3 7.4"0.4 2.02"0.26
 .Synchronized liver regeneration SLR
a aSynchronization period 1 d 258"12 5.8"0.4 4.2"0.5 2.24"0.30
a aRegenerative period 4 h 246"10 6.1"0.3 4.5"0.3 2.22"0.28
a1 d 276"15 6.5"0.2 5.4"0.4 1.63"0.24
3 d 232"12 5.2"0.4 5.6"0.5 2.09"0.30
a7 d 258"12 5.9"0.3 7.3"0.4 2.23"0.21
After two-thirds partial hepatectomy, rats were allowed to undergo normal liver regeneration or at 14 h after surgery they received an i.v. bolus injection of hydroxyurea
 .  .  .170 mmolr100g body weight followed by a continuous infusion 2.0 mmolrminr100g body weight for 10 h synchronized regeneration . Values are means"S.E. from
n G 5.
a p - 0.05, b p - 0.01, c p - 0.001 as compared with control non-hepatectomyzed animals by Bonferroni method of multiple range testing.
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Fig. 1. Bile acid output in control rats and in rats during normal
 .liver regeneration NLR, A that followed two-thirds partial
 .hepatectomy PH and after synchronization of regenerative pro-
 .  .cess by hydroxyurea HU treatment SLR, B . Bile was collected
 .for 1 h. Total bile acid BA output was calculated by adding the
output of all individual bile acid species separated, identified and
 .measured by GC–MS circles . Similarly, the results of HPLC
analysis of the same bile samples were used to calculate amidated
 .  .bile acid output triangles . Values are means"S.E. n G 5 .
) .Comparison with control p - 0.05 and between total and
† .amidated BAs p - 0.05 were carried out by the Bonferroni
method of multiple range testing.
remained higher than control levels, but from the
third day they became progressively closer to those
observed in non-hepatectomized rats.
Using HPLC, the major taurine- and glycine-con-
jugated bile acids were separated from fresh bile
samples and their amounts were measured. This ap-
proach revealed the existence during NLR of a pro-
file very similar to that observed for total bile acid
output as measured by GC–MS, except at the early
period of liver regeneration where significant differ-
ences between conjugated and total bile acid output
  ..were found Fig. 1 A . This suggests an enhance-
ment in the proportion of non-conjugated bile acids
in bile samples at 1 day after partial hepatectomy.
When total bile acid output was determined in
  ..SLR Fig. 1 B , a marked difference with NLR was
found. Following the initial increase occurring imme-
diately after partial hepatectomy, no effect due to HU
treatment was observed. This is consistent with a lack
of direct HU effect on bile acid secretion. To confirm
this point, following the same protocol of administra-
Fig. 2. Biliary output of taurine- and glycine-amidated bile acids
 .during normal liver regeneration NLR, A that followed two-
 .thirds partial hepatectomy PH in the rat and after synchronized
 .  .liver regeneration SLR, B , induced by hydroxyurea HU treat-
ment to partially hepatectomized rats. Bile samples collected over
1 h were used to carry out HPLC analysis. In the calculation of
amidated bile acid output, the following species were included:
for tauro-conjugates: TCA, TCDCA, TDCA, TLCA, TUDCA,
Ta MCA, Tb MCA; for glyco-conjugates: GCA, GCDCA,
GDCA, GLCA, GUDCA, Ga MCA, Gb MCA. Values are means
) ."S.E. Comparison with control p - 0.05 and between NLR
† .and SLR p - 0.05 were carried out by the Bonferroni method
of multiple range testing.
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Table 2
 .Bile acid secretion nmolrminrg liver in rats during normal or synchronized liver regeneration
 .BA Control Regenerative period days
NLR SLR
1 3 7 1 3 7
a a a a a aCA 12.17"1.31 41.13"4.39 32.45"4.30 18.69"1.96 19.0"1.77 23.27"4.68 29.17"3.98
DCA 0.92"0.17 1.64"0.71 0.57"0.19 0.94"0.03 0.54"0.43 0.57"0.38 1.22"0.59
a aCDCA 1.81"0.37 1.91"0.56 0.53"0.14 1.33"0.21 0.11"0.91 0.43"0.33 1.90"0.12
a a a aUCA 1.86"0.46 0.47"0.13 0.33"0.10 0.60"0.17 0.10"0.03 1.69"0.35 1.22"0.27
a aUDCA 0.40"0.14 0.29"0.09 0.19"0.14 0.35"0.10 0.01"0.01 0.06"0.06 0.27"0.12
HCA 0.07"0.04 0.04"0.02 ND 0.02"0.02 ND ND ND
a a aHDCA 0.82"0.16 2.46"0.21 0.97"0.10 1.79"0.56 0.21"0.17 0.19"0.06 1.34"1.18
a a aa MCA 1.56"0.23 4.10"1.05 1.48"0.29 3.01"0.42 0.29"0.15 0.90"0.83 5.37"1.26
a a a ab MCA 2.70"0.89 4.28"1.24 3.08"0.87 6.44"1.74 0.25"0.11 8.58"3.63 8.32"3.16
a a a a a avMCA 1.70"0.63 0.53"0.19 0.48"0.14 0.39"0.11 0.15"0.03 0.03"0.03 0.32"0.14
Allo-CA 0.02"0.02 0.07"0.05 0.46"0.24 a 0.35"0.07a 0.02"0.01 0.07"0.02 0.25"0.08 a
aOthers 1.82"0.31 1.93"0.35 1.57"0.42 2.76"0.52 0.10"0.04 1.86"0.46 1.44"0.31
 .After two-thirds partial hepatectomy, rats were allowed to undergo normal liver regeneration NLR or at 14 h after surgery they received
 . an i.v. bolus injection of hydroxyurea 170 mmolr100 g body weight followed by a continuous infusion 2.0 mmolrminr100 g body
.  .weight for 10 h synchronized liver regeneration, SLR . Values are means"S.E. from nG5.
a p-0.05 as compared with control non-hepatectomyzed animals by Bonferroni method of multiple range testing.
Fig. 3. Proportional amount of different bile acid molecular species as measured by GC–MS in bile samples collected for 1 h at the
 .indicated times during normal liver regeneration NLR that followed two-thirds hepatectomy. For comparison, the results obtained in
control non-hepatectomized rats are also depicted. Values are means"S.E. of the percentages of the amounts calculated by addition of all
) .bile acid species found in the chromatogram. Comparison with control p - 0.05 was carried out by the Bonferroni method of
multiple range testing.
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tion used with partially hepatectomized rats, two
separate sets of experiments were carried out on
non-hepatectomized rats that received saline Con-
.trol or HU for 10 h. In these animals, mean bile acid
 .output 32.1"5.1 nmolrminrg liver during the first
60 min after the end of HU administration was not
significantly different to that found in rats receiving
 .saline Control, Fig. 1 . By contrast, shortly after
stopping HU treatment in hepatectomized animals,
when the replicative process was resumed, a reduc-
tion in bile acid output leading to values slightly
lower than that found in control animals was ob-
served during the first day of regenerative process.
Thereafter, total bile acid output markedly increased
to reach values close to those of NLR at day 3. The
profile of conjugated bile acids according to HPLC
analysis matches that of total bile acids during the
first stage of SLR. However, the increase in bile acid
output observed on day 3 was not due to higher
conjugated bile acid secretion, but mainly to the
enhancement in the output of non-conjugated forms.
On day 7, the proportion of conjugated bile acids in
SLR was restored and therefore total and conjugated
  ..bile acid outputs were very similar Fig. 1 B .
When both taurine- and glycine-conjugated bile
acid outputs were compared in NLR versus SLR, the
following was observed: most bile acids were conju-
 .gated with taurine rather than with glycine Fig. 2 in
all experimental groups. However, bile secretion of
taurine-amidated bile acids significantly differs from
that of total bile acids. In NLR, the peak observed in
total bile acid output 1 day after partial hepatectomy
  ..Fig. 1 A was absent in taurine-conjugated bile
  ..acids Fig. 2 A . The reduction in conjugation with
taurine was more pronounced and was maintained in
  ..SLR Fig. 2 B . Only at the end of the regenerative
period did the amount of taurine-conjugated bile acids
become similar in NLR and SLR. Amidation with
Fig. 4. Proportional amount of different bile acid molecular species as measured by GC–MS in bile samples collected for 1 h at the
 .indicated times during synchronized liver regeneration SLR that followed two-thirds hepatectomy. For comparison, the results obtained
in control non-hepatectomized rats are also depicted. Values are means"S.E. of the percentages of the amounts calculated by addition of
) . † .all bile acid species found in the chromatogram. Comparison with control p - 0.05 and between NLR and SLR p - 0.05 were
carried out by the Bonferroni method of multiple range testing.
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glycine was not affected during most of the NLR or
 .SLR period Fig. 2 , except for a slight increase in
glycine-conjugated bile acid output observed at the
  ..end of the studied period in SLR Fig. 2 B . The
meaning of this is not known, but it may be related to
the general increase in bile acid output observed in
this experimental group.
Using GC–MS, study of the changes in the propor-
tion of different molecular species of bile acids was
 .investigated Table 2 . The results of such determina-
tions indicated a predominance of CA in all bile
samples, regardless of whether they belonged to
 .non-hepatectomized rats or to the NLR Fig. 3 or
 .SLR Fig. 4 experimental groups. Despite this, the
proportion of this bile acid changed during liver
regeneration. In NLR, the proportion of CA increased
1 day after partial hepatectomy and declined again
toward control values after the third day of liver
regeneration. This was mainly due to an increase in
CA output rather than a reduction in the proportion of
 .all other major bile acids Table 2 .
The changes in the proportion of secreted bile acid
species during SLR were similar to those observed in
NLR except for the fact that the increase in the
proportion of CA was more marked, and this was due
in part to a pronounced reduction in the proportion of
bile acids other than CA. Comparison between NLR
 .  .Fig. 3 and SLR Fig. 4 suggests that the quantita-
tive importance of the diversity in bile acid species
other than CA was recovered earlier in SLR than in
NLR. Finally, a minor bile acid in normal control rat
w xbile such as allo-cholic acid 29 , was increased
during both NLR and SLR and remained at de-
tectable levels up to 7 days of the regenerative period
 .Table 2 .
4. Discussion
The synthesis and canalicular secretion of bile
acids are specific functions of differentiated hepato-
cytes. A larger amount of these compounds must be
secreted per individual parenchymal liver cell early
on after partial hepatectomy due to an enhancement
w xin the relative bile acid pool size 10 . This accounts
for the increase in bile acid output observed just after
surgical removal of two-thirds of the liver mass. This,
in addition to circulatory changes, has usually been
related to an enhanced supply of bile acids per gram
of remaining liver tissue. Baumgartner et al. have
shown that serum bile acid concentrations increase
w xrapidly, peaking 6 h after resection 10 . Moreover, a
recruitment of pericentral cells and an acceleration of
biliary bile acid secretion, probably due to faster
vesicular transport in these cells, have been suggested
w xto occur at that time 10,14 . An ulterior maintenance,
or even an increase, in bile flow has been related to
the stimulation of ion flux, which has been suggested
to be necessary for rat hepatocyte proliferation to be
w xinitiated 30 . This is probably accounted for in part
by an enhancement in Naq, Kq-ATPase expression
w xduring the early phase of NLR 31 . During SLR, two
phases in bile flow enhancement were observed Ta-
.ble 1 . The latter one was more likely to be due to the
existence, immediately following the proliferation
wave, of a presumably large number of smaller but
already functional hepatocytes in the liver
parenchyma, which additionally contains less extra-
cellular matrix and fewer non-hepatocyte cells per
gram of tissue. As to why this is seen as two separate
bile flow peaks in SLR but not in NLR is not known,
but one could speculate that the more synchronous
and hence sharper proliferative wave in SLR would
render it easier to distinguish both stages of the
regenerative process. This hypothesis is further sup-
ported by the results obtained on bile acid secretion,
as will be discussed below.
Our results indicate the existence of an enhance-
ment in unconjugated bile acid output during NLR;
this was accompanied by an increase in the predomi-
nance of CA. This suggested a change in the activity
of the different pathways involved in bile acid
w xmetabolism 32 , probably leading to a simpler bile
acid pool composition. These findings agree with
previous studies on bile acid secretion during normal
w xliver regeneration 13 . It was interesting that an
enhancement in the proportion of CA was also found
by others in rat plasma during the early stages of
experimentally induced cirrhosis using a choline-defi-
w xcient diet 33 . This simplification in bile acid
metabolism has also been found in the SLR group. In
this case, the process was also transient, but sharper
with more pronounced loss of diversity in bile acid
species and probably with faster reversion to normal
situation. This is consistent with a more synchronous
development of the retro-differentiationrre-differ-
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entiation process of regenerating hepatocytes if, as
can be invoked, this is indeed involved in the tran-
sient modification of the proportion of bile acid
species secreted into bile during the early stage of
both NLR and SLR. Evidence for the existence of
retro-differentiationrre-differentiation processes in
the liver parenchyma include the change of zonal bile
acid uptake and secretion during liver regeneration,
w xcharacterized by a reduction in zonation 10 . This is
comparable to the situation observed in weaning rats,
where functional liver heterogeneity has not yet de-
veloped. However, a clear difference with the situa-
tion in the developing liver does exist. At least in
humans, the proportion of CA is reduced during fetal
life because total 12a-hydroxylase activity, responsi-
ble for committing 7a-hydroxy-cholest-4-en-3-one to
the synthesis of CA, is thought to be low in fetal
liver, thus increasing the fraction of 7a-hydroxy-
cholest-4-en-3-one that can be converted to CDCA
w x34 . This suggests the possibility that as far as bile
acid secretory function is concerned, retro-differentia-
tion leads the liver to a status similar in certain ways
but not absolutely to that of immaturity. An interest-
ing finding in both models is the increase in the
amount of a typically fetal bile acid species such as
w xallo-CA 35,36 , which is usually absent in healthy
adult male rat bile. This aspect further supports the
existence of retro-differentiation in the metabolic
pathways responsible for bile acid synthesis.
Although changes in the composition of secreted
bile acids were similar in both NLR and SLR, the
time course of the amount secreted into bile was
clearly different. The fact that bile acid output on day
1 in NLR increased above the values observed imme-
diately after partial hepatectomy, together with the
findings that this enhancement was mainly due to
unconjugated bile acids and that a change in the
proportion of bile acid species did exist, suggested
that in addition to the enlargement of the relative
pool size by removal of part of the liver, de novo bile
acid synthesis of bile acids was activated early on
during liver regeneration. In SLR, a marked decrease
in bile acid output was observed following the initial
increase. This was probably due to the existence of a
relatively large population of hepatocytes following
the cell cycle at the same time. These cells were
expected to partly or completely lose their ability to
normally synthesize and secrete bile acids. These
functions were quickly restored at day 3 of regenera-
tive period in SLR. As to why this nadir was not seen
in NLR is not known. However, a simple explanation
can be offered. The hepatocyte population able to
take up and secrete bile acids at any given time is
probably larger during NLR than during the prolifera-
tive wave of SLR. Thus, this decrease during NLR is
largely overcome by the enhancement in relative pool
size and the activation of bile acid synthesis.
A common finding in both NLR and SLR was the
modification of the proportion of conjugated bile
acids. Bile acid amidation was transiently impaired in
NLR during the first day after partial hepatectomy or
at least it was insufficient to accomplish the conjuga-
tion of increased amount of bile acids that were
therefore secreted as unconjugated forms. Because
amidation was mainly performed by using taurine as
the conjugating amino acid, one possible explanation
could be the existence of a decrease in the availabil-
ity of taurine for this metabolic pathway. However, it
is worth noting that taurine-conjugated bile acid out-
put was significantly higher than that observed in
control rats while minor changes in the output of
glycine-conjugated bile acid output were found. These
findings are consistent with previously reported re-
w xsults 15 showing an enhanced proportion of
taurine-conjugation following intravenous administra-
tion of unconjugated cholic or ursodeoxycholic acid
6 h after partial hepatectomy. Current study indicates
that although the predominance of taurine-conjugated
bile acid is increased early on after partial hepatec-
tomy, this is not enough to accomplish complete
amidation of bile acids secreted into bile by the
regenerating liver, regardless of whether this process
is normal or synchronized. Some experimental data
support the idea of the involvement of taurine in
w xgrowth control in several tissues 37 . Therefore,
changes in the activity of the metabolic pathways
involved in taurine biosynthesis, reported to occur
w xduring liver regeneration 38,39 , or in the distribu-
tion of synthesized taurine for purposes other than
bile acid conjugation, may play a role in the reduc-
tion of amino acids available for the apparently in-
creased substrate requirements needed for bile acid
amidation. Moreover, changes in the activity or ex-
pression of enzymes responsible for this process, i.e.,
 .cholyl-CoA synthetase EC 6.2.1.7. and bile acid-
 .CoA: amino acid N-acyltransferase EC 2.3.1. , can-
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not be ruled out. In this respect, it is interesting to
note that in the immature liver the low activity of
those enzymes accounts for the reduction in bile acid
w xconjugation that is observed in the suckling rat 40 .
In summary, the results obtained in this descriptive
study indicate that profound changes in bile acid
secretion during rat liver regeneration do occur. Most
of them are probably related to the existence of
retro-differentiationrre-differentiation processes
which are speeded up by hydroxyurea-induced syn-
chronization of the wave of hepatocyte proliferation.
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